Improved glycaemic control and less hypoglycaemia with insulin glargine compared with NPH insulin in patients with type 2 diabetes leads to fewer long-term complications -: Results of the Diabetes Mellitus Simulation Model

被引：0

作者：

Maxion-Bergemann, S

Müller, E

Bergemann, R

Walleser, S

Huppertz, E

机构：

[1] Inst Med Outcome Res, Lorrach, Germany

[2] Aventis Pharma Deutschland GMBH, Bad Soden am Taunus, Germany

来源：

VALUE IN HEALTH | 2003年 / 6卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)61725-1

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：674 / 675

页数：2

共 50 条

[41] Safety and Efficacy of Insulin Glargine Compared with NPH Insulin in Older Adults with Type 2 Diabetes: Results from a Pooled Analysis
Lee, Pearl G.
Chang, Annette M.
Blaum, Caroline S.
Vlajnic, Aleksandra A.
Miller, Michael F.
Halter, Jeffrey B.
[J]. DIABETES, 2009, 58 : A155 - A155
[42] Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine:: clinical practice experience from a German subgroup of the PREDICTIVE study
Meneghini, L. F.
Rosenberg, K. H.
Koenen, C.
Merilainen, M. J.
Luddeke, H. -J.
[J]. DIABETES OBESITY & METABOLISM, 2007, 9 (03): : 418 - 427
[43] Lower incidence of nocturnal hypoglycaemia in patients with Type 2 diabetes treated with insulin glargine compared with NPH insulin, given as a combination regimen with oral agents.
Benedetti, MM
Hamburg, E
Dressler, A
Ziemen, M
[J]. DIABETOLOGIA, 2002, 45 : A259 - A259
[44] A meta-analysis of phase III/IIIb studies comparing insulin glargine with human NPH insulin in Type 2 diabetes: severe hypoglycaemia is less common with insulin glargine.
Dailey, G
Riddle, M
Benedetti, MM
Fritsche, A
Lin, Z
Salzman, A
[J]. DIABETOLOGIA, 2003, 46 : A305 - A305
[45] Treatment to target in Type 2 diabetes: consistent risk reduction of hypoglycaemia with basal insulin glargine as compared with NPH insulin in insulin-naive patients on oral agents.
Rosenstock, J
Riddle, M
[J]. DIABETOLOGIA, 2002, 45 : A259 - A259
[46] Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy:: Comparison of insulin glargine with NPH insulin as basal insulin supplement
Ploeckinger, Ursula
Topuz, Mendaha
Riese, Brigitte
Reuter, Thomas
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 290 - 295
[47] Basal-bolus therapy with insulin degludec improves long-term glycaemic control with less nocturnal hypoglycaemia compared with insulin
Russell-Jones, D. L.
Francisco, A. O.
Pei, H.
Heller, S. R.
[J]. DIABETOLOGIA, 2011, 54 : S425 - S425
[48] Glycemic control with insulin glargine in patients with type 1 diabetes is maintained in long-term exposure
Dreyer, M
[J]. DIABETES, 2002, 51 : A129 - A129
[49] Insulin glargine and educational intervention in patients with type 2 diabetes in clinical practice: Long-term improvement in glycaemic control without weight gain
Schreiber, SA
Russmann, A
[J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (01) : 41 - 42
[50] Combining insulin glulisine with basal insulin glargine provides improved glycaemic control in patients with Type 2 diabetes in everyday clinical practice
Donaubauer, B.
Ferlinz, K.
Schreiber, S.
[J]. DIABETIC MEDICINE, 2008, 25

← 1 2 3 4 5 →